Spruce Biosciences (SPRB) Gains FDA Support for Accelerated Approval Pathway [Yahoo! Finance]
Spruce Biosciences, Inc. (SPRB)
Company Research
Source: Yahoo! Finance
Spruce Biosciences Inc. (NASDAQ: SPRB ) is one of the most promising micro-cap stocks according to analysts . On February 18, Spruce Biosciences recently concluded successful Type B meetings with the FDA, clearing a path for the BLA submission of tralesinidase alfa enzyme replacement therapy (TA-ERT). The Agency confirmed that existing clinical and natural history data could support an accelerated approval based on the reduction of heparan sulfate non-reducing end (HS-NRE) in cerebral spinal fluid. This biomarker is considered a reasonably likely surrogate endpoint, as Spruce showed that lowering these toxic levels is associated with meaningful improvements in cognition and motor skills for patients with Sanfilippo Syndrome Type B (MPS IIIB). To meet the FDA's Chemistry, Manufacturing, and Controls requirements, Spruce adjusted its BLA submission timeline to Q4 2026. This shift allows the company to complete the necessary process performance qualification batches for the drug produ
Show less
Read more
Impact Snapshot
Event Time:
SPRB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SPRB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SPRB alerts
High impacting Spruce Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
SPRB
News
- Spruce Biosciences to Present at Upcoming Investor Conferences in March [Yahoo! Finance]Yahoo! Finance
- Spruce Biosciences to Present at Upcoming Investor Conferences in MarchBusiness Wire
- Spruce Biosciences (NASDAQ:SPRB) had its "buy" rating reaffirmed by analysts at HC Wainwright.MarketBeat
- Spruce Biosciences Announces Positive Type B Meetings with U.S. FDA for TA-ERT for the Treatment of Sanfilippo Syndrome Type B (MPS IIIB)Business Wire
- Spruce Biosciences to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference [Yahoo! Finance]Yahoo! Finance
SPRB
Sec Filings
- 2/24/26 - Form SCHEDULE
- 2/18/26 - Form SCHEDULE
- 2/17/26 - Form SCHEDULE
- SPRB's page on the SEC website